Seo Jihye, Chu Hongmin, Kim Cheol-Hyun, Sung Kang-Keyng, Lee Sangkwan
Department of Oriental Gynecology, Se-Myung University Korean Medicine Hospital, Republic of Korea.
Department of Internal Medicine and Neuroscience, College of Korean Medicine, Wonkwang University, Iksan, Republic of Korea.
Evid Based Complement Alternat Med. 2021 Mar 24;2021:7582581. doi: 10.1155/2021/7582581. eCollection 2021.
Migraine is a common reason for primary headache disorders. Cupping is a frequently used traditional intervention for controlling pain including migraine. There have been no systematic reviews on the clinical effects of cupping on migraine.
This systematic review and meta-analysis aimed to evaluate the effectiveness of cupping therapy for migraine. The search strategy was built for the presence of related keywords, such as "migraine" and "cupping therapy", in the title and abstract of research articles indexed in the MEDLINE, EMBASE, CENTRAL, and other databases. The randomized controlled trials (RCTs) of cupping therapy for migraine were searched and selected from inception to May 2019. We searched eight databases including PubMed, EMBASE, Cochrane Central Register of Controlled Trials. The selection process and the quality assessment were performed by 2 authors independently. The meta-analysis was conducted and qualitative analysis was also performed.
218 studies were identified, and 6 RCTs were enrolled in this review. In comparison to drugs, wet cupping showed a higher total effective rate (TER). In the dry cupping plus acupuncture, the result of TER showed more effectiveness (RR 1.05, 95% CI 0.99 to 1.12, =0.13) compared with acupuncture alone, but there was no statistically significant difference. In qualitative analysis, the results showed wet cupping plus drugs treatment could quickly relieve pain and significantly improve patients' quality of life and wet cupping could reduce headache pain.
Cupping therapy could be effective for the treatment of migraine. However, the qualities of the evidence were low, so well-designed RCTs are needed to confirm the effectiveness of cupping. Systematic review registration: PROSPERO registration number is CRD42017054979.
偏头痛是原发性头痛疾病的常见原因。拔罐是一种常用于控制包括偏头痛在内的疼痛的传统干预方法。目前尚无关于拔罐治疗偏头痛临床效果的系统评价。
本系统评价和荟萃分析旨在评估拔罐疗法治疗偏头痛的有效性。检索策略是基于在MEDLINE、EMBASE、CENTRAL和其他数据库中索引的研究文章的标题和摘要中是否存在“偏头痛”和“拔罐疗法”等相关关键词构建的。检索并选取了从开始到2019年5月期间关于拔罐疗法治疗偏头痛的随机对照试验（RCT）。我们检索了包括PubMed、EMBASE、Cochrane对照试验中央登记册在内的8个数据库。筛选过程和质量评估由2位作者独立进行。进行了荟萃分析并进行了定性分析。
共识别出218项研究，本评价纳入了6项RCT。与药物相比，闪罐显示出更高的总有效率（TER）。在留罐加针刺组中，与单纯针刺相比，TER结果显示更有效（RR 1.05，95%CI 0.99至1.12，=0.13），但无统计学显著差异。在定性分析中，结果显示闪罐加药物治疗可快速缓解疼痛并显著改善患者生活质量，且闪罐可减轻头痛疼痛。
拔罐疗法可能对偏头痛治疗有效。然而，证据质量较低，因此需要设计良好的RCT来证实拔罐的有效性。系统评价注册：PROSPERO注册号为CRD42017054979。
